IP News & Updates
Enanta v Pfizer at the UPC: Paxlovid Patent Falls and the Lesson for Drug Patent Drafting
On 29 October 2026, the Unified Patent Court (UPC) held Enanta Pharmaceuticals’ patent EP 4 051 265 invalid and dismissed its Paxlovid…
Read Full Article